“Clinician- and Patient-Reported Outcomes With Tirbanibulin 1% Treatment for Actinic Keratosis in Routine Clinical Practice Across the U.S. (PROAK Study)”. SKIN The Journal of Cutaneous Medicine, vol. 7, no. 3, May 2023, pp. 771-87, https://doi.org/10.25251/skin.7.3.3.